CopyMark Law Group
4.9/5
Drawing for SIGHTSCORE

USPTO serial 98540038

SIGHTSCORE

Reviewed by CopyMark Law Group

Reg. 8393472Status 700Registered
Filing date
Status date
Registration date
Aug 11, 2026
Examiner
ROJAS, ELINA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SIGHTSCORE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Max Vern

Max Vern AMSTER, ROTHSTEIN & EBENSTEIN LLP405 Lexington AvenueNew York, NY 10174United States

Goods and services

ClassDescriptionStatusFirst use
005Reagents for medical or clinical testing in the nature of medical diagnostic reagents and assays for testing of bodily fluids; reagents for use in medical genetic testing; buccal and saliva swabs and preserving reagents for collecting DNA samples for medical or clinical testing; reagents for use in diagnostic testing for medical purposes; diagnostic kits comprised primarily of test reagents for use in medical testing; diagnostic kits comprised primarily of test reagents for use in medical genetic testingACTIVEJun 30, 2024
044Medical testing and medical clinical diagnostics, namely, medical and diagnostic testing services for risk assessment, screening, diagnosis and treatment of disease; ophthalmological testing; genetic testing and screening for medical purposes; medical testing, screening and analysis services utilising an on-line portal; medical testing, screening and analysis services utilising input of genetic and clinical data via an on-line portal; medical genetic analysis services, in particular, genome analysis, and genome scanning; medical genetic diagnostic testing, screening and reporting services; medical diagnostic testing, screening and reporting services; medical testing services, namely, medical testing and reporting services relating to the screening, diagnosis and treatment of disease; medical health advisory services; eye health advisory services; medical health assessment services; eye health screening; glaucoma testing and screeningACTIVEAug 1, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 11, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 11, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 23, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 23, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 16, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 16, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 16, 2026CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 31, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 1, 2025IUAFUSE AMENDMENT FILED—
Oct 1, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 1, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 4, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 4, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 29, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 10, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 21, 2024DOCKASSIGNED TO EXAMINER—
Nov 6, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 8, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance